Skip to content

Mechanism of cardiac and cerebral function injury in patients with coronary heart disease caused by intraoperative limb ischemia-reperfusion and perioperative organ function protection strategy

Mechanism of cardiac and cerebral function injury in patients with coronary heart disease caused by intraoperative limb ischemia-reperfusion and perioperative organ function protection strategy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066993
Enrollment
Unknown
Registered
2022-12-23
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia-reperfusion injury

Interventions

C group:Before induction of anesthesia, general anesthesia was performed after ultrasound-guided femoral nerve block
DEX group:Before induction of anesthesia, general anesthesia was performed after ultrasound-guided femoral nerve block. Dexmedetomidine 0.8µg/kg was pumped intravenously for 10min 15min before inducti
ERIPC group:Before induction of anesthesia, ultrasound-guided femoral nerve block was performed, and then general anesthesia was performed. After induction of anesthesia, orthopedic tourniquet was tie
LRIPC group:An orthopedic pressure tourniquet was placed on the lower extremity 24 h before surgery and inflated to 200 mmHg for 5 min and deflated for 5 min. Three cycles were repeated

Sponsors

The Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing TKA under general anesthesia; (2) Voluntarily sign the informed consent; (3) ASA Grade I to III; (4) BMI 18-28 kg/m2

Exclusion criteria

Exclusion criteria: (1) Congenital heart disease or history of cardiac surgery, heart conduction disease, frequent ventricular/atrial premature beats, atrial fibrillation and other serious arrhythmias; (2) Severe liver disease and kidney disease; (3) Temporary and permanent pacemaker implantation; (4) Patients with serious central nervous system diseases or serious mental disorders; (5) Recent history of sedation, antidepressant or opioid use; (6) Body mass index >35kg/m2; (7) Participants in other clinical trials within 1 month prior to study enrollment.

Design outcomes

Primary

MeasureTime frame
SOD;MDA;IL-6;TNF-a;hs-Tn;BDNF;

Countries

China

Contacts

Public ContactXiu-Li Wang

The Third Hospital of Hebei Medical University

wangxl301@aliyun.com18533112928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026